60 Degrees Pharmaceuticals (SXTP) Stock Chart & Stock Price History $1.26 -0.04 (-3.08%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.28 +0.02 (+1.59%) As of 08/22/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock 60 Degrees Pharmaceuticals Stock Price Performance The 60 Degrees Pharmaceuticals (SXTP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 86.08%, with a year-to-date return of -80.47%. In the past month, the stock has decreased 5.97%, reflecting recent market activity. As of the latest close, 60 Degrees Pharmaceuticals traded at $1.26 with a market cap of $1.85 million and volume of 33,058 shares. Receive SXTP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.56%1 Month Performance-5.97%3 Month Performance-37.31%Year-To-Date Performance-80.47%1 Year Performance-86.08% SXTP Stock Chart for Sunday, August, 24, 2025 SXTP Chart by TradingView 60 Degrees Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$1.30$1.26-3.08%$1.29$1.2633,058 shs$1.85 million08/21/2025$1.27$1.30+2.36%$1.30$1.2620,928 shs$1.92 million08/20/2025$1.28$1.27-0.78%$1.30$1.2636,445 shs$1.87 million08/19/2025$1.30$1.28-1.54%$1.30$1.2783,538 shs$1.88 million08/18/2025$1.32$1.30-1.52%$1.35$1.2937,387 shs$1.91 million08/15/2025$1.31$1.32+0.76%$1.33$1.2840,473 shs$1.94 million08/14/2025$1.35$1.31-2.96%$1.37$1.24148,261 shs$1.93 million08/13/2025$1.35$1.35$1.40$1.3298,460 shs$1.99 million08/12/2025$1.38$1.35-2.17%$1.39$1.3259,068 shs$1.99 million08/11/2025$1.39$1.38-0.72%$1.40$1.3591,656 shs$2.03 million Get the Latest News and Ratings for SXTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$1.32$1.39+5.30%$1.39$1.30145,916 shs$2.05 million08/07/2025$1.35$1.32-1.86%$1.36$1.27168,720 shs$1.94 million08/06/2025$1.38$1.35-2.54%$1.44$1.33169,969 shs$1.98 million08/05/2025$1.34$1.38+2.99%$1.39$1.3085,586 shs$2.03 million08/04/2025$1.33$1.34+0.75%$1.38$1.31103,704 shs$1.97 million08/01/2025$1.34$1.33-0.75%$1.36$1.26113,709 shs$1.96 million07/31/2025$1.38$1.34-2.90%$1.40$1.32143,346 shs$1.97 million07/30/2025$1.33$1.38+3.76%$1.43$1.33249,900 shs$2.03 million07/29/2025$1.28$1.33+3.91%$1.37$1.28242,330 shs$1.96 million07/28/2025$1.31$1.28-2.29%$1.34$1.28115,652 shs$1.88 million07/25/2025$1.34$1.31-2.24%$1.34$1.28109,633 shs$1.93 million07/24/2025$1.34$1.34$1.37$1.34105,176 shs$1.97 million07/23/2025$1.33$1.34+0.75%$1.40$1.30150,970 shs$1.97 million Related Companies TRAW Stock Chart KZIA Stock Chart MBIO Stock Chart BCLI Stock Chart APM Stock Chart ARTL Stock Chart PMCB Stock Chart ALZN Stock Chart SBFM Stock Chart CDIO Stock Chart Receive SXTP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SXTP) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access